GlycoEra AG, a biotechnology company pioneering best-in-class extracellular protein degraders for the treatment of autoimmune diseases, today announced the appointment of Andrea Matthews as Chief Business Officer.
“We are delighted to welcome Andrea to GlycoEra’s leadership team,” said Ganesh Kaundinya, Ph.D., Chief Executive Officer of GlycoEra. “Andrea brings deep strategic experience in public biotech companies and transactions, with a proven track record of helping companies advance their science and create value. As we continue to advance our pipeline and expand the reach of our platform, her expertise will be instrumental in helping GlycoEra realize its vision of bringing transformative medicines to patients.”
